Skip to main content

Table 1 Characteristics of study patients at the time of diagnosis of hepatocellular carcinoma by hepatitis B presentation group

From: Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study

 

Type of presentation

p-value

Late presentation

N (%)

Irregular visits

N (%)

Regular visits

N (%)

Number of patients

413

527

336

 

Sex

   

0.15

 Male

343 (83.1)

415 (78.7)

262 (78.0)

 

 Female

70 (17.0)

112 (21.3)

74 (22.0)

 

Age (years)

   

0.15

  ≥ 40 – <  50

105 (25.4)

106 (20.1)

64 (19.0)

 

  ≥ 50 – <  60

165 (40.9)

230 (43.6)

163 (48.5)

 

  ≥ 60

143 (34.6)

191 (36.2)

109 (32.4)

 

Income percentile

   

< 0.001

  ≤ 30th

107 (25.9)

155 (29.4)

62 (18.5)

 

  > 30th – ≤ 70th

155 (37.5)

196 (37.2)

113 (33.6)

 

  > 70th

151 (36.6)

176 (33.4)

161 (47.9)

 

Initial treatment

   

< 0.001

 Liver transplantation

0 (0)

1 (0.2)

1 (0.3)

 

 Resection

40 (6.7)

59 (11.2)

60 (17.9)

 

 RFA

3 (0.7)

23 (4.4)

28 (8.3)

 

 TACE

193 (46.7)

219 (41.6)

140 (41.7)

 

 Other

95 (23.1)

116 (22.0)

50 (14.9)

 

 No treatment

82 (19.9)

109 (20.7)

57 (17.0)

 

Residential area

   

0.12

 Metropolitan

248 (60.1)

328 (62.2)

226 (67.3)

 

 Rural

165 (39.9)

199 (37.8)

110 (32.7)

 
  1. RFA radiofrequency ablation, TACE transarterial chemoembolization.Income percentile is based on household income